欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4213/001
药品名称Emtricitabine/Tenofovirdisoproxil Accordpharma
活性成分
    • emtricitabine 200.0 mg
    • TENOFOVIR DISOPROXIL FUMARATE 300.0 mg
剂型Film-coated tablet
上市许可持有人Accord Healthcare B.V. Winthontlaan 200 3526 KV Utrecht The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Emtricitabine/Tenofovir disoproxil Accordpharma 200 mg/245 mg filmomhulde tabletten RVG 122434
互认成员国 - 产品名称
    • Denmark (DK)
    • Iceland (IS)
      Emtricitabine/Tenofovir disoproxil Accordpharma 200 mg/245 mg filmuhúðuð tafla
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Emtricitabin/Tenofovirdisoproxil Accordpharma 200 mg/245 mg Filmtabletten
    • Spain (ES)
    • Sweden (SE)
    • Norway (NO)
      Emtricitabine/Tenofovir disoproxil Accordpharma
    • Finland (FI)
    • Latvia (LV)
      Emtricitabine/Tenofovir disoproxil Accordpharma 200 mg/245 mg apvalkotās tabletes
    • Lithuania (LT)
      Emtricitabine/Tenofovir disoproxil Accordpharma 200 mg/245 mg plėvele dengtos tabletės
    • Estonia (EE)
      EMTRICITABINE/TENOFOVIR DISOPROXIL ACCORDPHARMA
    • Hungary (HU)
      EMTRICITABINE/TENOFOVIR DISOPROXIL ACCORDPHARMA 200 mg/245 mg filmtabletta
    • Slovenia (SI)
      Emtricitabin/dizoproksiltenofovirat Accordpharma 200 mg/245 mg filmsko obložene tablete
许可日期2019/04/03
最近更新日期2024/09/03
药物ATC编码
    • J05AR03 tenofovir disoproxil and emtricitabine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase